World | ANALYSIS Jul 13, 2021
Pfizer bid for booster vaccines premature, experts say, with more data needed
by Julie Steenhuysen and Michael Erman
The drugmaker's push for health regulators to authorize a third dose of its COVID-19 shot is not yet backed by evidence, despite the fast-spreading delta variant, vaccine experts said.
